References
- Aickin M, Gensler H (1996) Adjusting for multiple testing when reporting research results: the Bonferroni vs. Holm methods. Am. J. Public Health 86: 726–728.
- Arturi F, Succurro E, Procopio C, Pedace E, Mannino GC, Lugarà M, Procopio T, Andreozzi F, Sciacqua A, Hribal ML, Perticone F, Sesti G (2011) Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I. J. Clin. Endocrinol. Metab. 96: E1640–E1644.
- Assy N, Hochberg Z, Amit T, Shen-Orr Z, Enat R, Baruch Y (1997) Growth hormone stimulated insulin-like growth factor (IGF) I and IGF binding protein-3 in liver cirrhosis. J. Hepatol. 27: 796–802.
- Bonefeld K, Møller S (2011) Insulin-like growth factor-I and the liver. Liver Int. 31: 911–919.
- Carrillo MC, Kanai S, Nokubo M, Ivy GO, Sato Y, Kitani K (1992) Deprenyl increases activities of superoxide dismutase and catalase in striatum but not in hippocampus: the sex and age-related differences in the optimal dose in the rat. Exp. Neurol. 116: 286–294.
- Castagne V, Gautschi M, Lefevre K, Posada A, Clarke PG (1999) Relationships between neuronal death and the cellular redox status. Focus on the developing nervous system. Prog. Neurobiol. 59: 397–423.
- Ceballos I, Delabar JM, Nicole A, Lynch RE, Hallewell RA, Kamoun P, Sinet PM (1988) Expression of transfected human Cu Zn superoxide dismutase gene in mouse L cells and NS20Y neuroblastoma cells induces enhancement of glutathione peroxidase activity. Biochim. Biophys. Acta 949: 58–64.
- Csiszar A, Labinskyy N, Perez V, Recchia FA, Podlutsky A, Mukhopadhyay P, Losonczy G, Pacher P, Austad SN, Bartke A, Ungvari Z (2008) Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice. Am. J. Physiol. Heart Circ. Physiol. 295: H1882–H1894.
- Darmaun D, Smith SD, Sweeten S, Sager BK, Welch S, Mauras N (2005) Evidence for accelerated rates of glutathione utilization and glutathione depletion in adolescents with poorly controlled type 1 diabetes. Diabetes 54: 190–196.
- De Palo EF, Bassanello M, Lancerin F, Spinella P, Gatti R, D’Amico D, Cillo U (2001) GH/IGF system, cirrhosis and liver transplantation. Clin. Chim. Acta 310: 31–37.
- Donahue AN, Aschner M, Lash LH, Syversen T, Sonntag WE (2006) Growth hormone administration to aged animals reduces disulfide glutathione levels in hippocampus. Mech. Ageing Dev. 127: 57–63.
- Fracanzani AL. Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, Bertelli C, Fatta E, Bignamini D, Marchesini G, Fargion S (2008) Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology 48: 792–798.
- Fraser A, Harris R, Sattar N, Ebrahim S, Davey Smith G, Lawlor DA (2009) Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and Meta-analysis. Diabetes Care 32: 741–750.
- Frystyk J (2004) Free insulin-like growth factors measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm. IGF Res. 14: 337–375.
- Frystyk J, Ivarsen P, Skjaerbaek C, Flyvbjerg A, Pedersen EB, Orskov H (1999) Serum-free insulin like growth factor I correlate with clearance in patients with chronic renal failure. Kidney Int. 56: 2076–2084.
- Gaunt GL, De Duve C (1991) Subcellular distribution of diamino acid oxidase and catalase in rat brain. J. Neurochem. 26: 749–759.
- Guven A, Yavuz O, Cam M, Ercan F, Bukan N, Comunoglu C, Gokce F (2006) Effects of melatonin on streptozotocin-induced diabetic liver injury in rats. Acta Histochem. 108: 85–93.
- Halliwell B (1992) Reactive oxygen species and the central nervous system. J. Neurochem 59: 1609–1623.
- Ioannou GN, Boyko EJ, Lee SP (2006) The prevalence of predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am. J. Gastroenterol. 101: 76–82.
- Juul A (2003) Serum levels of insulin-like growth factor-I and its binding proteins in health and disease. Growth Horm. IGF Res. 13: 113–170.
- Karatopuk DU, Gokcimen A (2010) Effect of tenoxicam on rat liver tissue. Turk. J. Gastroenterol. 21: 146–152.
- Kaur K, Bhatia H, Datta M (2011) MicroRNAs in hepatic pathophysiology in diabetes. World J. Diabetes 2: 158–163.
- Mayhan WG, Faraci FM (1993) Responses of cerebral arterioles in diabetic rats to activation of ATP-sensitive potassium channels. Am. J. Physiol. 265: 152–157.
- Messeri S, Messerini L, Vizzutti F, Laffi G, Marra F (2012) Glycogenic hepatopathy associated with type 1 diabetes mellitus as a cause of recurrent liver damage. Ann. Hepatol. 11: 554–558.
- Misawa E, Tanaka M, Nomaguchi K, Nabeshima K, Yamada M, Toida T, Iwatsuki K (2012) Oral ingestion of aloe vera phytosterols alters hepatic gene expression profiles and ameliorates obesity-associated metabolic disorders in zucker diabetic fatty rats. J. Agric. Food Chem. 60: 2799–2806.
- Mukherjee B, Mukherjee JR, Chatterjee M (1994) Lipid peroxidation, glutathione levels and changes in glutathione-related enzyme activities in streptozotocin-induced diabetic rats. Immunol. Cell Biol. 72: 109–114.
- Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S (2008) The current state of serum biomarkers of hepatotoxicity. Toxicology 245: 194–205.
- Park CH, Noh JS, Kim JH, Tanaka T, Zhao Q, Matsumoto K, Shibahara N, Yokozawa T (2011) Evaluation of morroniside, iridoid glycoside from Corni fructus, on diabetes-induced alterations such as oxidative stress, inflammation, and apoptosis in the liver of type 2 diabetic db/db mice. Biol. Pharm. Bull. 34: 1559–1565.
- Ross AP, Bruggeman EC, Kasumu AW, Mielke JG, Parent MB (2012) Non-alcoholic fatty liver disease impairs hippocampal-dependent memory in male rats. Physiol. Behav. 106: 133–141.
- Rückert IM, Heier M, Rathmann W. Baumeister SE, Döring A, Meisinger C (2011) Association between markers of fatty liver disease and impaired glucose regulation in men and women from the general population: the KORA-F4-study. PLoS One 6: 1–11.
- Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87: 4–14.
- Sies H (1999) Glutathione and its role in cellular functions. Free Radic. Biol. Med. 27: 916–921.
- Uysal N, Yalaz G, Acikgoz O, Gonenc S, Kayatekin BM (2005) Effect of L-carnitine on diabetogenic action of streptozotocin in rats. Neuro. Endocrinol. Lett. 26: 419–422.
- Wu YL, Ye J, Zhang S, Zhong J, Xi RP (2004) Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis. World J. Gastroenterol. 10: 2740–2743.
- Yang JY, Kang MY, Nam SH, Friedman M (2012) Antidiabetic effects of rice hull smoke extract in alloxan-induced diabetic mice. J. Agric. Food Chem. 60: 87–94.